Hirschsprung Disease
|
0.500 |
PosttranslationalModification
|
disease |
BEFREE |
The blood level of Sox10 promoter methylation at the 32nd locus was 100% (90%-100%; 95% confidence interval [CI], 92.29%-96.37%) in control, 90% (80%-90%; 95% CI, 82.84%-87.83%) in HD, and 60% (50%-80%; 95% CI, 57.12%-69.76%) in IND specimens.
|
31789936 |
2019 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We suggest that hypoganglionosis can be a variant intestinal manifestation associated with PCWH and that hypoganglionosis and aganglionosis may share the same pathoetiological mechanism mediated by SOX10 mutations.
|
29681101 |
2018 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
It has been postulated that PCWH as a combination of Waardenburg and Hirschsprung disease, peripheral neuropathy and central leukodystrophy is caused by heterozygous SOX10 mutations that result in the presence of a dominantly acting mutant SOX10 protein in the patient.
|
29361054 |
2018 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The subject's phenotype evolved to include peripheral and central demyelination, Waardenburg syndrome type IV, and Hirschsprung disease (PCWH; MIM 609136).
|
28328136 |
2017 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
SOX10 mutations are usually associated with a more severe phenotype of WS with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, and Hirschsprung disease.
|
28544110 |
2017 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We previously identified an intronic enhancer variant in the RET gene disrupting SOX10 binding and increasing Hirschsprung disease (HSCR) risk 4-fold.
|
27693352 |
2016 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
As dominant mutations in mouse or human SOX10 cause white spotting and intestinal aganglionosis, we screened the Sox10 coding region for mutations in gt/gt DNA.
|
25399070 |
2015 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SOX10 were first associated with Waardenburg-Hirschsprung disease (WS4; deafness, pigmentation defects and intestinal aganglionosis).
|
26060192 |
2015 |
Hirschsprung Disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
We identified 3 mutations in GLI in 5 patients with Hirschsprung disease but no controls; all lead to increased transcription of SOX10 in cell lines.
|
26261006 |
2015 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Molecular analysis detected a de novo p.Leu145Pro mutation in SOX10, which has previously been reported in a patient with WS and Hirschsprung disease.
|
26228106 |
2015 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
SOX10 mutations have been found in patients with type II and type IV WS (i.e., with Hirschsprung disease), more complex syndromes, and partial forms of the disease.
|
24845202 |
2014 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
An impairment of long distance SOX10 regulatory elements underlies isolated Hirschsprung disease.
|
24357527 |
2014 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Impairments of endothelin receptor B (EDNRB) and SOX10 have been shown to cause a significantly increased risk of dominant sensorineural deafness in Hirschsprung disease (HSCR) patients.
|
22295143 |
2012 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The recent identification of a deletion encompassing three of the SOX10 regulatory elements in a patient presenting with another WS subtype, WS4, defined by its association with Hirschsprung disease, led us to search for deletions and point mutations within the MITF and SOX10 regulatory elements in 28 yet unexplained WS2 cases.
|
22848661 |
2012 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In this study we describe a case of a term infant with the neurological variant of Waardenburg syndrome type 4 (i.e., PCWH = peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease, as defined in OMIM #609136) due to a novel heterozygous base exchange (c.671C>G) in exon 4 of SOX10.
|
22246888 |
2012 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
We describe a male infant with a novel SOX10 mutation and a severe course of PCWH--a special phenotype of Shah-Waardenburg syndrome involving peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung's disease.
|
21822601 |
2011 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Association analysis of the SOX10 polymorphism with Hirschsprung disease in the Han Chinese population.
|
22008330 |
2011 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Developmental processes were investigated in congenic Sox10(Dom) mice, an established Hirschsprung disease (HSCR) model, on distinct inbred backgrounds, C57BL/6J (B6) and C3HeB/FeJ (C3Fe).
|
20739296 |
2010 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
This is the first time that a SOX10 mutation is detected in an isolated HSCR patient, which completely changes the scenario for the implications of SOX10 mutations in human disease, giving us a new tool for genetic counseling.
|
20130826 |
2010 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
The involvement of SOX10 and ZFHX1B in Waardenburg-Hirschsprung disease (hypopigmentation, deafness, and absence of enteric ganglia) and Mowat-Wilson syndrome (mental retardation, facial dysmorphy and variable congenital malformations including Hirschsprung disease) respectively, highlighted the importance of both transcription factors during enteric nervous system (ENS) development.
|
20206619 |
2010 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
In sum, Phox2b and Sox10 act together with Nkx2.1 to modify RET signaling and this interaction may also contribute to HSCR susceptibility.
|
19853745 |
2009 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease.
|
18348267 |
2008 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease.
|
18348267 |
2008 |
Hirschsprung Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
These results suggest that the enteric nervous system in patients with SOX10-associated Hirschsprung's disease is entirely subject to neuroglial impairment.
|
17448776 |
2007 |
Hirschsprung Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) is a complex neurocristopathy caused by SOX10 mutations.
|
17855451 |
2007 |